Should we take another hard look?
-
Yes and no. Both China and a Russia have an ‘approved’ vaccine. But they’re basically doing phase 3 with a different name - ‘limited rollout’.
True, they’ll hit a bigger N and will show safety and efficacy earlier. But (a) we won’t necessarily be able to trust their data and (b) the drugs aren’t identical, so it doesn’t help us approve ours any quicker.
-
@jon-nyc said in Should we take another hard look?:
Yes and no. Both China and a Russia have an ‘approved’ vaccine. But they’re basically doing phase 3 with a different name - ‘limited rollout’.
True, they’ll hit a bigger N and will show safety and efficacy earlier. But (a) we won’t necessarily be able to trust their data and (b) the drugs aren’t identical, so it doesn’t help us approve ours any quicker.
I am talking about pressure to move fast. Results will go viral even if people challenge them. We going to just sit there? Really? I doubt it.
-
Listen to Moderna’s, AZ’s, or Pfizer’s earnings calls. Nobody’s just sitting around.
-
@Jolly said in Should we take another hard look?:
At an old drug?
Why give "the media" power over what drugs to promote, what drugs to bury?
For that matter, why give any politician power over what drugs to promote, what drugs to bury?Let the medical establishment do their thing and you pay attention to the medical establishment. The CDC, the FDA, the WHO, the revered academic journals ... pay attention to those.
Yeah, from time to time, they make mistakes.
But they are still a lot than "the media", a lot better than just about any politician. -
As if on cue.
But it’s the AZ. Probably a wiser choice, it’s the one the Russians stole so it’s gotten more testing.
-
@jon-nyc said in Should we take another hard look?:
I think Trump will push hard for a late October approval, or at least some creative rebranding of the trial status to make it seem like a pre-election victory.
From the CNBC piece:
One option, according to the FT report, would involve the U.S. Food and Drug Administration awarding “emergency use authorization” for the vaccine, which was developed by Oxford University and AstraZeneca.
-
Funny thing is AZ hasn’t even started recruiting for their big n=30k P3 trial in the US.
They do have an n=5k trial in Brazil though which started dosing last quarter.
-
Oh wow. The administration told GOP lawmakers they would approve a vaccine before the election but weren’t sure which one. AZ is just considered the best candidate.
-
@Axtremus said in Should we take another hard look?:
@Jolly said in Should we take another hard look?:
At an old drug?
Why give "the media" power over what drugs to promote, what drugs to bury?
For that matter, why give any politician power over what drugs to promote, what drugs to bury?Let the medical establishment do their thing and you pay attention to the medical establishment. The CDC, the FDA, the WHO, the revered academic journals ... pay attention to those.
Yeah, from time to time, they make mistakes.
But they are still a lot than "the media", a lot better than just about any politician.Lad, if you don't think politics enter into the world of Big Pharma, you are naive.